MedTrace Logo

The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care

NCT07461493 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100000

Last updated 2026-04-08

No results posted yet for this study

Summary

The goal of this observational study is to establish a patient registry and a biorepository (sample collection and storage) to investigate health disparities, access, and barriers to cancer screening and early detection technologies. The registry and biorepository will serve as a resource to support Cancer Early Detection (CED) screenings and future research focused on communities at increased risk for cancer.

The study seeks to address:

•Barriers and disparities in cancer prevention, screening, and treatment, particularly in historically underrepresented populations.

Participants will:

* Attend a minimum of five clinic visits over a five-year period for scheduled annual assessments while actively enrolled in the study.
* Complete questionnaires at each visit that collect information on their medical history, cancer history, and family cancer history.
* Allow relevant health information from their electronic health records (EHR) to be collected and reviewed.
* Provide blood, saliva, and stool samples for research purposes.
* Enter a long-term follow-up period for an additional five years.

Conditions

Sponsors & Collaborators

  • National Minority Quality Forum

    lead OTHER

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-11
Primary Completion
2034-03-31
Completion
2039-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07461493 on ClinicalTrials.gov